» Articles » PMID: 29247483

Peptidoglycan Synthesis in Tannerella Forsythia: Scavenging is the Modus Operandi

Overview
Specialties Dentistry
Microbiology
Date 2017 Dec 17
PMID 29247483
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Tannerella forsythia is a Gram-negative oral pathogen strongly associated with periodontitis. This bacterium has an absolute requirement for exogenous N-acetylmuramic acid (MurNAc), an amino sugar that forms the repeating disaccharide unit with amino sugar N-acetylglucosamine (GlcNAc) of the peptidoglycan backbone. In silico genome analysis indicates that T. forsythia lacks the key biosynthetic enzymes needed for the de novo synthesis of MurNAc, and so relies on alternative ways to meet its requirement for peptidoglycan biosynthesis. In the subgingival niche, the bacterium can acquire MurNAc and peptidoglycan fragments (muropeptides) released by the cohabiting bacteria during their cell wall breakdown associated with cell division. Tannerella forsythia is able to also use host sialic acid (Neu5Ac) in lieu of MurNAc or muropeptides for its survival during the biofilm growth. Evidence suggests that the bacterium might be able to shunt sialic acid into a metabolic pathway leading to peptidoglycan synthesis. In this review, we explore the mechanisms by which T. forsythia is able to scavenge MurNAc, muropeptide and sialic acid for its peptidoglycan synthesis, and the impact of these scavenging activities on pathogenesis.

Citing Articles

Microbial dysbiosis in periodontitis and peri-implantitis: pathogenesis, immune responses, and therapeutic.

Cui Z, Wang P, Gao W Front Cell Infect Microbiol. 2025; 15:1517154.

PMID: 40007610 PMC: 11850578. DOI: 10.3389/fcimb.2025.1517154.


Tannerella forsythia scavenges Fusobacterium nucleatum secreted NOD2 stimulatory molecules to dampen oral epithelial cell inflammatory response.

Settem R, Ruscitto A, Chinthamani S, Honma K, Sharma A Mol Oral Microbiol. 2023; 39(2):40-46.

PMID: 37459655 PMC: 10792118. DOI: 10.1111/omi.12429.


Persistence of and in dental plaque: a strategic alliance.

Sharma A Curr Oral Health Rep. 2023; 7(1):22-28.

PMID: 36779221 PMC: 9917731. DOI: 10.1007/s40496-020-00254-6.


Investigating Peptidoglycan Recycling Pathways in with -Acetylmuramic Acid Bioorthogonal Probes.

Wodzanowski K, Hyland S, Chinthamani S, Sandles L, Honma K, Sharma A ACS Infect Dis. 2022; 8(9):1831-1838.

PMID: 35924866 PMC: 9464701. DOI: 10.1021/acsinfecdis.2c00333.


Metabolomics Research in Periodontal Disease by Mass Spectrometry.

Tsuchida S, Nakayama T Molecules. 2022; 27(9).

PMID: 35566216 PMC: 9104832. DOI: 10.3390/molecules27092864.


References
1.
Radford-Smith G, Pandeya N . Associations between NOD2/CARD15 genotype and phenotype in Crohn's disease--Are we there yet?. World J Gastroenterol. 2006; 12(44):7097-103. PMC: 4087769. DOI: 10.3748/wjg.v12.i44.7097. View

2.
Settem R, El-Hassan A, Honma K, Stafford G, Sharma A . Fusobacterium nucleatum and Tannerella forsythia induce synergistic alveolar bone loss in a mouse periodontitis model. Infect Immun. 2012; 80(7):2436-43. PMC: 3416462. DOI: 10.1128/IAI.06276-11. View

3.
Hayashi H, Araki Y, Ito E . Occurrence of glucosamine residues with free amino groups in cell wall peptidoglycan from bacilli as a factor responsible for resistance to lysozyme. J Bacteriol. 1973; 113(2):592-8. PMC: 285270. DOI: 10.1128/jb.113.2.592-598.1973. View

4.
Sharma A . Virulence mechanisms of Tannerella forsythia. Periodontol 2000. 2010; 54(1):106-16. PMC: 2934765. DOI: 10.1111/j.1600-0757.2009.00332.x. View

5.
Sharma A, Inagaki S, Sigurdson W, Kuramitsu H . Synergy between Tannerella forsythia and Fusobacterium nucleatum in biofilm formation. Oral Microbiol Immunol. 2004; 20(1):39-42. DOI: 10.1111/j.1399-302X.2004.00175.x. View